Rafarma Pharmaceuticals Overview
Get informed when a big investor buys or sells
+ Follow10.43
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, RAFA shows a P/E ratio of 10.43. That is below the sector sector average of 27.12. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 27.12. Rafarma Pharmaceuticals is at 10.43, which is lower that average. That is roughly 61.5% below the sector mean. Use the comparison chart on this page to see how RAFA stacks up against individual peers as well.
Investors watch RAFA's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Rafarma Pharmaceuticals's latest reading is 10.43. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Rafarma Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 10.43) with ownership activity and broader fundamentals.
